500009 — Ambalal Sarabhai Enterprises Share News
0.000.00%
Last trade - 00:00- IN₹2.90bn
- IN₹3.26bn
- IN₹2.02bn
Brief: Ambalal Sarabhai Enterprises Says CFO Navinchandra Patel Resigns
Brief: Ambalal Sarabhai Enterprises Names Mohal K. Sarabhai As MD
Brief: Ambalal Sarabhai Enterprises Says Unit Asence Pharma Commences New Oncology And Synthetic API Plant At Ranoli, Vadodara
Brief: India's Ambalal Sarabhai Enterprises Dec-Qtr Consol Net Profit Falls
Approved Vesting Of Oncology, Profertility Division Of Sarabhai Chemicals
Brief: Ambalal Sarabhai Ups Production Of Amphotericin B In Wake Of Mucormycosis Outbreak
Brief: Ambalal Sarabhai Enterprises -JV Gets CDSCO License To Manufacture Saragene Chikungunya Virus Test Kit
Brief: Ambalal Sarabhai Changes Consideration, Completion Date For Synbiotics Sale
Brief: India's Ambalal Sarabhai Enterprises Dec-Qtr Consol Net PAT Rises
Brief: Ambalal Sarabhai Enterprises Says JV Got Permission To Manufacture COVID-19 Test
Brief: Ambalal Sarabhai Enterprises Says Share Purchase Agreement With Asence Pharma
Brief: Ambalal Sarabhai Enterprises Sept-Qtr Consol Net PAT Rises
Brief: India's Ambalal Sarabhai Enterprises March Quarter Consol Net Profit Rises
Brief: Ambalal Sarabhai Enterprises Says Unit's JV Granted Manufacturing License For Covid‐ 19 Rt‐Pcr Test Kits
Brief: Cosara Diagnostics Has Started Import & Marketing Of COVID-19 Test Kits In India
Brief: Ambalal Sarabhai Enterprises- JV Of Unit Gets Test License To Make Covid-19 Diagnostic Test Kits
Brief: Ambalal Sarabhai Enterprises Says Cosara Diagnostics Gets Clearance For 5 Tests To Be Made, Sold As In Vitro Diagnostics From Ranoli Facility
Brief: Ambalal Sarabhai Enterprises Appoints Navinchandra Patel CFO
Brief: Ambalal Sarabhai Enterprises Appoints Bharat Bhogilal Shah As CFO